Sign in

CIK 0001000694 · Large accelerated filer

NOVAVAX INC

Sign in to watch
Ticker
NVAX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
222816046
Phone
240-268-2000
Business address
21 FIRSTFIELD RD, GAITHERSBURG, MD
  1. S-3 Offering Registration Statement
  2. DEF 14A Proxy Proxy Statement
  3. 10-K405 Other 10-K405
  4. NT 10-K Other NT 10-K
  5. SC 13G Stake Amended Statement of Ownership
  6. SC 13G Stake Amended Statement of Ownership
  7. 8-K Event Item 5 · Item 7
  8. 10-Q Report Quarterly Report
  9. 10-Q Report Quarterly Report
  10. 10-Q Report Quarterly Report
  11. DEF 14A Proxy Proxy Statement
  12. 10-K/A Report 10-K/A
  13. 10-K Report Annual Report
  14. PRER14A Other PRER14A
  15. PRE 14A Proxy Proxy Statement (Preliminary)
  16. S-3 Offering Registration Statement
  17. 10-Q Report Quarterly Report
  18. 10-Q Report Quarterly Report
  19. 10-Q Report Quarterly Report
  20. SC 13G Stake Amended Statement of Ownership

Page 82 of 83 · 1,649 filings